Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Vaccine Information Center

FDA Urges HCPs to Follow Authorized Dosing Schedules for COVID-19 Vaccines

Diana Ernst, RPh

January 14, 2021

Additional research from the vaccine manufacturers would be needed to support any changes to the dosing schedule.

HIV/AIDS Information Center

Counterfeit HIV Drug Identified in 3 US Pharmacies

Diana Ernst, RPh

January 4, 2021

The counterfeit products were procured from unauthorized distributors.

Infectious Diseases Information Center

FDA Authorizes COVID-19 Test That Provides Rapid Results at Home

Diana Ernst, RPh

November 24, 2020

This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.

Gastroenterology Information Center

FDA Approves Sulfate-Based Tablet Prep for Colonoscopy

Diana Ernst, RPh

November 18, 2020

Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.

Vaccine Information Center

Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective

Diana Ernst, RPh

November 17, 2020

The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.

Infectious Diseases Information Center

COVID-19 Vaccine Candidate More Than 90% Effective, Say Pfizer, BioNTech

Diana Ernst, RPh

November 10, 2020

The trial will continue as planned and final analysis is expected when the number of confirmed COVID-19 cases reaches 164.

Vaccine Information Center

COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study

Diana Ernst, RPh

September 25, 2020

The Medicines Health Regulatory Authority confirmed that the AZD1222 trial could proceed after a UK committee concluded its investigations.

Infectious Diseases Information Center

Remdesivir Emergency Use Authorization Expanded to Include All Hospitalized COVID-19 Patients

Diana Ernst, RPh

September 4, 2020

Previously, the EUA limited use to patients with severe COVID-19 disease.

Influenza Information Center

ACIP: Influenza Vaccination Recommendations for 2020-2021

Diana Ernst, RPh

September 2, 2020

Influenza vaccination should occur by the end of October, if possible.

Infectious Diseases Information Center

Phase 3 Trial of COVID-19 Vaccine Candidate mRNA-1273 Begins

Diana Ernst, RPh

July 30, 2020

The trial, which is the first to be implemented under Operation Warp Speed, is expected to enroll around 30,000 adults and will be conducted at multiple clinical research sites across the US.

Next post in Infectious Diseases Information Center